Gilead Sciences Inc at Evercore ISI Healthcare Conference Transcript
Thank you guys for joining. Super excited to have Dietmar join us from Gilead. I know we spent time at your prior company as well. So how has the transition been? And how are things going on the West Coast?
Transition has -- first of all, thanks for having me. Transition has been great. I'm with Gilead since a year. I've always been excited about the science and the people and the impact that Gilead has. And what I found is exactly in line with that. I'm really excited -- it has been going well. We've had good data during the year. Obviously, we have different launches going on. We have the portfolio focus on virology, oncology, and inflam. So it's been a really good year.
Questions & Answers
Fantastic. We're going to focus this conversation today more so on R&D. I know we had Andy with us earlier as well. I was hoping Jacquie would join us, but Jacquie is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
